Novel Endovascular Access Trial (NEAT)

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

October 31, 2016

Conditions
Chronic Kidney Disease
Interventions
DEVICE

The FLEX System will be used to percutaneously create a fistula in CKD patients who require hemodialysis vascular access

Trial Locations (9)

1142

Auckland City Hospital, Grafton

3181

Alfred Hospital, Melbourne

4102

Princess Alexandra Hospital, Woolloongabba

V6Z 1Y6

St. Paul's Hospital, Vancouver

B3H 2Y9

QE II Health Sciences Center, Halifax

N6A 5W9

London Health Sciences Centre, London

L1G 2B9

Lakeridge Health Oshawa, Oshawa

M5G 2C4

The Toronto General Hospital, Toronto

H2L 4M1

CHUM, Notre-Dame Hospital, Montreal

All Listed Sponsors
lead

TVA Medical Inc.

INDUSTRY

NCT02036671 - Novel Endovascular Access Trial (NEAT) | Biotech Hunter | Biotech Hunter